06/09/2022

Giovannelli e Associati assisted Investindustrial on the sale of Benvic Compounds

Investindustrial Growth, global private equity fund targeted to the mid market, entered into a sale agreement with the German-based International Chemical Investors Group regarding the chemical compound division, producing thermoplastic […]
10/08/2022

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas

Giovannelli e Associati assisted Neopharmed Gentili, a pharmaceutical company specializing in the commercialization of high-value therapeutic solutions controlled by Ardian together with the Del Bono family, in the acquisition of […]
14/07/2022

Giovannelli e Associati with Dedalus on the acquisition of the “healthcare division” of Lutech

Dedalus entered into an agreement for the acquisition of Lutech’s healthcare business unit, concerning the development and commercialization of digital medical records (so-called “wHealth”) and laboratory middleware (so-called “wLab”). Giovannelli […]
30/06/2022

Giovannelli e associati with P&P Holding on the sale of a majority stake to Riello Investimenti Partners Sgr

Giovannelli e Associati assisted P&P Holding, the nonoperating parent company of Protec Surface Technologies and Protim, on the sale of a majority stake to Riello Investimenti Partners Sgr. Protec Surface […]